Page last updated: 2024-08-23

etoposide and Alopecia

etoposide has been researched along with Alopecia in 82 studies

Research

Studies (82)

Timeframe	Studies, this research(%)	All Research%
pre-1990	25 (30.49)	18.7374
1990's	29 (35.37)	18.2507
2000's	20 (24.39)	29.6817
2010's	8 (9.76)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnold, R; Djabali, K; Henriques, G; Liu, C	1
Aerts, JG; Gras, J; Hoogsteden, H; Pouw, E; Pronk, T; Salomé, J; Schmitz, PI; Surmont, V; Tan, KY; van Klaveren, RJ; Vernhout, R	1
Aldabbagh, K; Fabbro, M; Jacot, W; Pouderoux, S; Poujol, S; Roca, L; Romieu, G	1
Fanti, PA; Misciali, C; Miteva, M; Romanelli, P; Tosti, A; Vincenzi, C	1
Amini, S; Elgart, G; Jimenez, JJ; Mauro, LM; Schachner, LA; Simon, J; Wikramanayake, TC	1
Jimenez, JJ; Mauro, LM; Nouri, K; Perez, CI; Schachner, LA; Villasante, AC; Wikramanayake, TC	1
Fu, K; Hao, XS; Hou, Y; Li, LF; Li, W; Liu, XM; Qian, ZZ; Qiu, LH; Wang, HQ; Zhang, HL; Zhou, SY	1
Baptista, AM; Belfort, P	1
Li, AW; Liu, JM; Luo, J; Wu, FY; Zheng, D	1
Chamberlain, MC	2
Acquati, M; Ardizzoia, A; Casartelli, C; Fagnani, D; Fusco, O; Giordano, M; Malugani, F; Quattrone, A; Scanni, A; Tagliabue, P; Vergani, C; Visini, M	1
Takahata, K; Tsuruki, T; Yoshikawa, M	3
Ito, A; Takaha, K; Tsuruki, T; Yoshikawa, M	1
Aimé, P; Coninx, P; Legros, M; Mérol, JC; Moutel, K; Nasca, S; Prévost, A; Roger-Liautaud, F	1
Tsuruki, T; Yoshikawa, M	2
Alberts, SR; Erlichman, C; Furth, A; Lathia, CD; Molina, JR; Reid, JM; Safgren, SL; Sloan, JA	1
Fukasawa, K; Izumi, M; Kamiyama, J; Kawa, S; Maruyama, S; Nikaido, T; Sakai, T; Sukenaga, Y; Takahara, Y; Wakada, M; Watanabe, N; Yogosawa, S; Yokoyama, H; Yoshizawa, K; Zhang, H	1
Bo, LJ; Chen, YH; Jin, XP; Liang, AB; Liu, B; Wang, F	1
Asoh, S; Mori, T; Nakashima-Kamimura, N; Nishimaki, K; Ohta, S	1
Aisner, J; Wiernik, PH	1
Canellos, GP; Garnick, MB; Lederman, GS; Richie, JP	1
Choo, YC; Ma, HK; Wong, LC	1
Hattori, K; Ito, K; Kobayashi, S; Nakamura, S; Nakanishi, J; Ohtake, S; Yoshida, T	1
Demitrish, M; Duffin, H; Enochs, K; Groshko, G; Lockhard, C; Maniscalco-Greb, E; Vaughn, CB	1
Hussein, AM; Peters, WP; Stuart, A	1
Albeck, M; Bruderman, I; Catane, R; Kalechman, Y; Kaufman, B; Shani, A; Shapira, J; Sredni, B; Tichler, T	1
Allen, SL; Behr, J; Budman, DR; Hock, K; Igwemezie, LN; Kaul, S; Kolitz, J; Lichtman, S; Schulman, P; Vinciguerra, V	1
Ashley, S; Holborn, J; Jones, AL; Smith, IE	1
Fukuda, H; Hosokawa, K; Kondo, H; Ohtsu, A; Saito, D; Shimada, Y; Shirao, K; Yamao, T; Yoshida, S	1
Kamijima, S; Kato, Y; Kobayashi, H; Kuwahara, M; Mihara, H; Nagasaka, T; Oguri, T; Takeda, H	1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L	1
Chen, S; Lee, BC; Miller, AA; Molthrop, DC; Robert, F; Wheeler, RH	1
Copplestone, A; Couteaux, ME; Deconinck, E; Economopoulos, T; Fenaux, P; Foussard, C; Guerci, A; Hecquet, B; Mahé, B; Michaux, JL; Mufti, G; Oscier, D; Pegourié, B; Resegotti, L; Stoppa, AM; Voglova, V; Wattel, E	1
Akbulut, H; Cay, F; Demirkazik, A; Dinçol, D; Içli, F; Karaoguz, H	1
Inoda, H; Kutsuki, M; Mori, M; Nishikawa, M; Nishimura, K; Takigami, K; Yamaguchi, Y; Yamamoto, C; Yoshitake, K	1
Bergman, B; Chemaissani, A; Dornoff, W; Drings, P; Kellokumpu-Lehtinen, P; Liippo, K; Manegold, C; Mattson, K; Ricci, S; Sederholm, C; Stahel, P; ten Bokkel Huinink, W; van Walree, N; von Pawel, J; Wagenius, G	1
Pienta, KJ; Smith, DC	1
Hara, N; Hirose, N; Inutsuka, S; Kanegae, H; Kawarada, Y; Kurita, Y; Miyazaki, M; Miyazaki, N; Nakanishi, Y; Ninomiya, K; Ogata, K; Ohgushi, O; Yamazaki, H	1
Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Liu, JH; Tung, SL; Wang, WS; Yen, CC	1
Chao, Y; Chen, LT; Chen, YM; Chiou, TC; Hsieh, RK; Liu, JM; Liu, SM; Tiu, CM; Whang-Peng, J; Wu, HW	1
Adachi, I; Inaji, H; Kanda, K; Kikkawa, N; Koyama, H; Miura, S; Nakao, K; Shiba, E; Tajima, T; Takai, S; Tamura, K; Toge, T; Yoshida, M	1
Benjamin, RS; Gano, J; Gianan, MA; Jaffe, N; Jia, SF; Kleinerman, ES; Papadopoulos, NE; Patel, S; Raymond, AK; Rodriguez, C; Worth, LL	1
Fujii, S; Hasegawa, K; Hirabayasi, K; Ikeda, M; Izumi, R; Kono, I; Kudo, R; Niitani, H; Nishiya, I; Noda, K; Ochiai, K; Ogita, Y; Okada, H; Ozaki, M; Saito, T; Sugimori, H; Suzuoki, Y; Tanaka, K; Terashima, Y; Tomoda, Y; Umesaki, N; Yajima, A; Yakushiji, M; Yamabe, T; Yamamoto, T	1
Asamoto, H; Furuse, K; Iwami, F; Kawahara, M; Kuba, M; Saijo, N; Shimoyama, M; Tamura, T	1
Hatae, M; Hiura, M; Hoshiai, H; Ikeda, M; Izumi, R; Noda, K; Ogita, Y; Okada, H; Ozaki, M; Ozawa, M; Tamaya, T; Tanaka, K; Yamabe, T	1
Astoul, P; Boutin, C; Gouvernet, J; Irisson, M; Juin, P; Pignon, T; Ruggieri, S	1
Tada, M; Takahata, K; Tamaki, T; Yazawa, K	1
Bamias, A; Katsimbri, P; Pavlidis, N	1
Bilgrami, S; Bona, RD; Edwards, RL; Feingold, JM; Kapur, D; Khan, AM; Rodriguez-Pinero, F; Tutschka, PJ	1
Benson, BG; Bramson, HN; Chapman, DE; Davis, ST; Dickerson, SH; Dold, KM; Eberwein, DJ; Edelstein, M; Frye, SV; Gampe, RT; Griffin, RJ; Harris, PA; Hassell, AM; Holmes, WD; Hunter, RN; Knick, VB; Kuyper, LF; Lackey, K; Lovejoy, B; Luzzio, MJ; Murray, D; Parker, P; Rocque, WJ; Shewchuk, L; Veal, JM; Walker, DH	1
Marx, J	1
Hosaka, Y; Kato, K; Mochizuki, H; Muramatsu, H; Nagata, S; Nakamura, N; Nakayama, K; Ohmori, Y; Saitoh, F; Takiguchi, K; Tsuda, T	1
Christodoulou, C; Efstathiou, E; Klouvas, G; Papazachariou, E; Plyta, M; Skarlos, DV; Zervakis, D	1
Bunn, PA; Ihde, DC; Radice, PA	1
Decker, DG; Edmonson, JH; Jorgensen, EO; Malkasian, GD; Webb, MJ	1
Jimenez, JJ; Yunis, AA	1
Bernacer, B; Candel, MT; Garcia, J; Jimeno, J; Villar-Grimalt, A	1
Achterrath, W; Eiermann, W; Hepp, H; Lenaz, L	1
Chasen, MR; Falkson, G; Falkson, HC	1
Hurukawa, H; Iwanaga, T; Numata, N; Ohshiba, S; Ohta, J; Ohtani, T; Okazima, K; Orino, M; Taguchi, T; Yamada, S	1
de Góes, GM; Simon, SD; Srougi, M	1
Bungo, M; Fujita, J; Futami, H; Hashimoto, Y; Hata, Y; Irino, S; Iuchi, Y; Kamei, M; Nakamura, H; Yamaji, Y	1
Achterrath, W; Meyer, D; Nagel, GA; Rauschning, W; Wander, HE	1
Boossy, J; Focan, C; Schallier, D; Vandermoten, G	1
Kimura, K; Niitani, H	1
Furuse, K	1
Hara, K; Kado, M; Kanda, T; Matsui, Y; Oshima, S; Shima, K; Shimokata, K; Takenaka, S	1
Hiraga, Y; Ito, T; Konno, K; Nagahama, F; Nakabayashi, T; Nakai, Y; Oizumi, K; Sato, M; Takebe, K; Tamura, M	1
Allan, NC; Dawson, AA; Leonard, RC; Lucraft, HH; McGillivray, JB; Parker, AC; Prescott, RJ; Proctor, SJ	1
Bishop, JF; Cobcroft, R; Dodds, A; Joshua, DE; Kronenberg, H; Lowenthal, RM; Manoharan, A; Whiteside, MG; Wolf, M	1
De Lena, M; Lorusso, V; Romito, S	1
Suzuki, K	1
Dent, DM; Hayes, M; Jacobs, P; King, HS	1
Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S	1
Kimura, K; Yamada, K; Yoshida, T	1
Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T	1
Felman, IE; Gala, KV; Grunberg, SM; Johnson, KB; Owens, JC	1

Trials

31 trial(s) available for etoposide and Alopecia

Article	Year
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study. Lung cancer (Amsterdam, Netherlands), 2009, Volume: 66, Issue:3 Topics: Administration, Oral; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Tegafur; Uracil	2009
Salvage chemotherapy for recurrent spinal cord ependymona. Cancer, 2002, Sep-01, Volume: 95, Issue:5 Topics: Administration, Oral; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Spinal Cord Neoplasms; Thrombocytopenia; Treatment Outcome; Weight Loss	2002
Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study. Lung, 2004, Volume: 182, Issue:1 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophagitis; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes; Premedication; Remission Induction; Stomatitis; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2004
A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck. Oncology reports, 2005, Volume: 14, Issue:3 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Survival Analysis; Treatment Outcome; Vomiting	2005
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biphenyl Compounds; Carboplatin; Cohort Studies; Colonic Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Male; Matrix Metalloproteinase Inhibitors; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Neutropenia; Organic Chemicals; Phenylbutyrates; Thrombocytopenia; Thymoma; Treatment Outcome; Vomiting	2005
[Phase II study of etoposide (NK 171) in advanced hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukemia; Leukopenia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin; Prednisolone; Thrombocytosis; Vincristine	1984
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Colony-Stimulating Factors; Ethylenes; Etoposide; Female; Humans; Interleukin-1; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Thrombocytopenia	1995
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9 Topics: Adult; Aged; Alopecia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Organophosphorus Compounds; Prodrugs; Regression Analysis; Solubility; Vomiting	1994
CVM versus ACE in the treatment of small cell lung cancer. Oncology, 1993, Volume: 50 Suppl 2 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Infections; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Thrombocytopenia; Treatment Outcome; Vinblastine	1993
An early phase II study of etoposide (VP-16) in advanced gastric cancer. Japanese journal of clinical oncology, 1996, Volume: 26, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Alopecia; Anemia; Antineoplastic Agents, Phytogenic; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Stomach Neoplasms	1996
Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:5 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Creatinine; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Mouth Mucosa; Neoplasms; Statistics, Nonparametric; Stomatitis	1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group. Blood, 1996, Oct-01, Volume: 88, Issue:7 Topics: Adult; Aged; Alopecia; Blood Cell Count; Cross-Over Studies; Etoposide; Female; Humans; Hydroxyurea; Karyotyping; Leukemia, Myelomonocytic, Chronic; Life Tables; Male; Middle Aged; Prognosis; Risk Factors; Splenomegaly; Survival Analysis; Treatment Outcome	1996
Recurrent cerebellar gliomas: salvage therapy with oral etoposide. Journal of child neurology, 1997, Volume: 12, Issue:3 Topics: Adolescent; Alopecia; Antineoplastic Agents, Phytogenic; Astrocytoma; Cerebellar Neoplasms; Child; Child, Preschool; Diarrhea; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Salvage Therapy; Survival Analysis	1997
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer. Journal of surgical oncology, 1997, Volume: 64, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Vomiting	1997
[CPE chemotherapy for tongue carcinoma--clinical effects and side effects]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:7 Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Peplomycin; Tongue Neoplasms; Vomiting	1997
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer. Seminars in oncology, 1997, Volume: 24, Issue:3 Suppl 8 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Metastasis; Ribonucleotide Reductases; Treatment Outcome; Vomiting	1997
Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer. Seminars in oncology, 1997, Volume: 24, Issue:5 Suppl 15 Topics: Adenocarcinoma; Administration, Oral; Alopecia; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; DNA Replication; DNA, Neoplasm; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Estramustine; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Microtubules; Nuclear Matrix; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Rats; Remission Induction; Tumor Cells, Cultured	1997
Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:6 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Survival Rate; Treatment Outcome; Vomiting	1998
Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer. Japanese journal of clinical oncology, 1998, Volume: 28, Issue:5 Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Prognosis; Stomach Neoplasms; Survival Analysis	1998
[Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:11 Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Receptors, Estrogen; Vomiting	1998
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10 Topics: Adolescent; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Capillary Leak Syndrome; Combined Modality Therapy; Cytokines; Drug Synergism; Etoposide; Feasibility Studies; Female; Femoral Neoplasms; Fever; Fibrosis; Gastrointestinal Diseases; Humans; Hypotension; Immunologic Factors; Interleukin-1; Lung Neoplasms; Male; Neutropenia; Osteosarcoma; Recombinant Proteins; Remission Induction; Respiration Disorders; Salvage Therapy; Treatment Outcome	1997
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Uterine Cervical Neoplasms	1998
Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group. Japanese journal of clinical oncology, 1998, Volume: 28, Issue:12 Topics: Administration, Oral; Adult; Aged; Alopecia; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vomiting	1998
[Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Nausea; Uterine Cervical Neoplasms; Vomiting	1998
Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma. Cancer, 1999, May-15, Volume: 85, Issue:10 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiotherapy; Survival Analysis; Treatment Outcome; Vomiting, Anticipatory	1999
Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:6 Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cryotherapy; Docetaxel; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Scalp; Taxoids	2000
Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia. Oncology, 2002, Volume: 62, Issue:2 Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Hypothermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasms; Paclitaxel; Scalp; Severity of Illness Index; Treatment Outcome	2002
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies. Cancer treatment reports, 1979, Volume: 63, Issue:8 Topics: Alopecia; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Evaluation; Etoposide; Humans; Leukemia; Leukopenia; Lung Neoplasms; Lymphoma; Podophyllotoxin; Teniposide	1979
[Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:11 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms	1990
VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma. Cancer, 1985, Sep-01, Volume: 56, Issue:5 Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Podophyllotoxin; Prognosis; Prospective Studies; Random Allocation	1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. American journal of clinical oncology, 1985, Volume: 8, Issue:5 Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting	1985

Other Studies

51 other study(ies) available for etoposide and Alopecia

Article	Year
Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells. Cells, 2019, 10-18, Volume: 8, Issue:10 Topics: Adenosine Triphosphate; Alopecia; Arthritis; Autophagy; Azetidines; Blotting, Western; Cell Cycle; Cells, Cultured; Cellular Senescence; Child; Child, Preschool; Data Mining; Etoposide; Female; Humans; Immunohistochemistry; Inflammation; Janus Kinase 1; Janus Kinase 2; Lamin Type A; Lipodystrophy; Male; Mutation; Progeria; Purines; Pyrazoles; Reactive Oxygen Species; STAT1 Transcription Factor; STAT3 Transcription Factor; Sulfonamides; Vascular Diseases	2019
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study. Breast cancer (Tokyo, Japan), 2012, Volume: 19, Issue:1 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Etoposide; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate	2012
Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. The American Journal of dermatopathology, 2011, Volume: 33, Issue:4 Topics: Alopecia; Antineoplastic Agents; Busulfan; Cisplatin; Dermis; Diagnosis, Differential; Docetaxel; Etoposide; Female; Hair; Humans; Male; Neoplasms; Taxoids	2011
A novel rat model for chemotherapy-induced alopecia. Clinical and experimental dermatology, 2012, Volume: 37, Issue:3 Topics: Alopecia; Animals; Antineoplastic Agents; Cyclophosphamide; Disease Models, Animal; Etoposide; Hair Follicle; Rats; Rats, Long-Evans	2012
Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA). Lasers in medical science, 2013, Volume: 28, Issue:3 Topics: Alopecia; Animals; Antineoplastic Agents; Cyclophosphamide; Disease Models, Animal; Doxorubicin; Etoposide; Female; Hair; Hair Follicle; Hair Removal; Humans; Low-Level Light Therapy; Male; Mice; Rats; Wound Healing	2013
[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:4 Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult	2012
Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 119, Issue:1 Topics: Adult; Alopecia; Antineoplastic Agents; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Nausea; Pregnancy; Prospective Studies; Remission Induction; Stomatitis; Vitamin B Complex; Vomiting; Young Adult	2012
Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Vinblastine	2012
A soy-derived immunostimulating peptide inhibits etoposide-induced alopecia in neonatal rats. The Journal of investigative dermatology, 2004, Volume: 122, Issue:3 Topics: Adjuvants, Immunologic; Alopecia; Animals; Etoposide; N-Formylmethionine Leucyl-Phenylalanine; Peptides; Rats; Rats, Sprague-Dawley; Soybean Proteins	2004
FPRL1 receptor agonist peptides prevent etoposide-induced alopecia in neonatal rats. The Journal of investigative dermatology, 2004, Volume: 123, Issue:1 Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Etoposide; N-Formylmethionine Leucyl-Phenylalanine; Rats; Receptors, Formyl Peptide; Receptors, Lipoxin	2004
Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy beta-conglycinin. Peptides, 2005, Volume: 26, Issue:5 Topics: Adjuvants, Immunologic; Administration, Oral; Alopecia; Animals; Antigens, Plant; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cyclooxygenase Inhibitors; Etoposide; Female; Globulins; Histamine H1 Antagonists; Indomethacin; Male; N-Formylmethionine Leucyl-Phenylalanine; NF-kappa B; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Pyrrolidines; Rats; Receptors, Formyl Peptide; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Seed Storage Proteins; Soybean Proteins; Thiocarbamates	2005
Anti-alopecia effect of Gly-Leu-Phe, an immunostimulating peptide derived from alpha-lactalbumin. Bioscience, biotechnology, and biochemistry, 2005, Volume: 69, Issue:8 Topics: Adjuvants, Immunologic; Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Etoposide; Lactalbumin; Oligopeptides; Rats	2005
Orally administered FPRL1 receptor agonist peptide MMK-1 inhibits etoposide-induced alopecia by a mechanism different from intraperitoneally administered MMK-1. Peptides, 2006, Volume: 27, Issue:4 Topics: Administration, Oral; Alopecia; Animals; Cimetidine; Disease Models, Animal; Etoposide; Female; Indomethacin; Injections, Intraperitoneal; Male; Peptides; Pyrilamine; Rats; Receptors, Formyl Peptide; Receptors, Lipoxin	2006
Lysocellin, a metabolite of the novel drug 'alopestatin', induces G1 arrest and prevents cytotoxicity induced by etoposide. International journal of oncology, 2006, Volume: 28, Issue:4 Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Area Under Curve; Blotting, Northern; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Down-Regulation; Etoposide; Female; Furans; G1 Phase; Gene Expression; Humans; Male; Osteosarcoma; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Up-Regulation	2006
[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult	2006
Mechanism of the protective effect of intraperitoneally administered agonists for formyl peptide receptors against chemotherapy-induced alopecia. Bioscience, biotechnology, and biochemistry, 2007, Volume: 71, Issue:5 Topics: Alopecia; Animals; Etoposide; Female; Injections, Intraperitoneal; Male; N-Formylmethionine Leucyl-Phenylalanine; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Formyl Peptide	2007
Prevention of chemotherapy-induced alopecia by the anti-death FNK protein. Life sciences, 2008, Jan-16, Volume: 82, Issue:3-4 Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Cell Cycle Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Etoposide; Hair Follicle; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Protective Agents; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Recombinant Fusion Proteins; tat Gene Products, Human Immunodeficiency Virus	2008
Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung. Cancer, 1980, Dec-15, Volume: 46, Issue:12 Topics: Aged; Agranulocytosis; Alopecia; Antineoplastic Agents; BCG Vaccine; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prognosis; Prospective Studies; Vomiting	1980
Chemotherapy of refractory germ cell cancer with Etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:11 Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Choriocarcinoma; Cisplatin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Male; Mesonephroma; Nausea; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Retroperitoneal Neoplasms; Testicular Neoplasms	1983
Oral etoposide in gestational trophoblastic disease. Cancer treatment reports, 1984, Volume: 68, Issue:5 Topics: Adolescent; Adult; Alopecia; Chorionic Gonadotropin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Nausea; Parity; Podophyllotoxin; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms	1984
VP-16 and adriamycin in patients with advanced breast cancer. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Podophyllotoxin; Prednisone; Thrombocytopenia; Vincristine; Vomiting	1982
Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model. Dermatology (Basel, Switzerland), 1995, Volume: 190, Issue:3 Topics: Administration, Cutaneous; Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Cyclophosphamide; Cyclosporine; Cytarabine; Disease Models, Animal; Etoposide; Injections, Intraperitoneal; Rats; Rats, Sprague-Dawley	1995
Oral low-dose etoposide therapy for refractory multiple myeloma with extramedullary involvement. Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:10 Topics: Administration, Oral; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Male; Multiple Myeloma; Prednisolone; Procarbazine; Remission Induction	1995
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6 Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia	1996
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections. Japanese journal of clinical oncology, 1998, Volume: 28, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cisplatin; Drug Administration Schedule; Etoposide; Female; Hepatitis B; Hepatitis C; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Taiwan; Thrombocytopenia; Virus Diseases	1998
Protection from chemotherapy-induced alopecia by docosahexaenoic acid. Lipids, 1999, Volume: 34 Suppl Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Cytarabine; Docosahexaenoic Acids; Etoposide; Female; In Situ Nick-End Labeling; Rats; Rats, Sprague-Dawley	1999
A novel combination of paclitaxel, etoposide, and cyclophosphamide for stem cell mobilization and tumor cytoreduction in ovarian cancer. Journal of hematotherapy & stem cell research, 2000, Volume: 9, Issue:2 Topics: Alopecia; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Carcinoma, Papillary; Cyclophosphamide; Endometrial Neoplasms; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Klebsiella Infections; Leukapheresis; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Serous Membrane; Taxoids	2000
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science (New York, N.Y.), 2001, 01-05, Volume: 291, Issue:5501 Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2-CDC28 Kinases; Cell Cycle; Cell Line; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cyclophosphamide; Cytoprotection; DNA; Doxorubicin; Drug Design; Enzyme Inhibitors; Epithelium; Etoposide; Hair Follicle; Humans; Indoles; Mice; Mice, SCID; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Retinoblastoma Protein; Scalp; Sulfonamides; Transplantation, Heterologous	2001
Cancer research. Preventing hair loss from chemotherapy. Science (New York, N.Y.), 2001, Jan-05, Volume: 291, Issue:5501 Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CDC2-CDC28 Kinases; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cyclophosphamide; Doxorubicin; Enzyme Inhibitors; Etoposide; Humans; Mice; Protein Serine-Threonine Kinases; Rats	2001
Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia. European journal of pharmacology, 2001, Dec-14, Volume: 433, Issue:1 Topics: Alopecia; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; COS Cells; Cyclohexanones; Enzyme Activation; Etoposide; Fas Ligand Protein; fas Receptor; Female; Hepatitis; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; U937 Cells	2001
Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents. Gynecologic oncology, 1978, Volume: 6, Issue:1 Topics: Alkylating Agents; Alopecia; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Nausea; Ovarian Neoplasms; Podophyllotoxin; Vomiting	1978
Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3. Cancer research, 1992, Sep-15, Volume: 52, Issue:18 Topics: Alkylating Agents; Alopecia; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cyclophosphamide; Doxorubicin; Etoposide; Rats; Rats, Inbred Strains	1992
Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:4 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Vascular Diseases	1991
Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study. Cancer chemotherapy and pharmacology, 1991, Volume: 27, Issue:5 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Pilot Projects; Thrombocytopenia; Vomiting	1991
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer. Investigational new drugs, 1990, Volume: 8, Issue:2 Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Mesna; Middle Aged; Nausea; Ovarian Neoplasms; Sarcoma, Ewing; Testicular Neoplasms; Vomiting	1990
Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience. The Journal of urology, 1985, Volume: 134, Issue:1 Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Dysgerminoma; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Time Factors; Vinblastine; Vomiting	1985
[Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:6 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Pilot Projects; Remission Induction; Thrombocytopenia	1989
Phase II study with etoposide in previously untreated advanced breast cancer. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4 Topics: Adult; Aged; Alopecia; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Tolerance; Etoposide; Female; Humans; Injections, Intravenous; Leukopenia; Middle Aged; Pilot Projects; Platelet Count; Remission Induction	1989
Oral etoposide preceding cisplatin in advanced non small cell lung cancer (NSCLC). A phase II study. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prognosis	1988
[A phase II study of NK171 (etoposide)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:10 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin	1985
[A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:12 Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Fatigue; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin	1985
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin	1986
[A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1 Topics: Adult; Aged; Alopecia; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin	1986
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphoma. Scottish medical journal, 1988, Volume: 33, Issue:6 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Nausea; Prednisone; Prognosis; Remission Induction; Vincristine; Vindesine	1988
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia. Australian and New Zealand journal of medicine, 1986, Volume: 16, Issue:1 Topics: Acute Disease; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis; Vomiting	1986
Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma. Cancer treatment reports, 1986, Volume: 70, Issue:7 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Middle Aged; Nausea; Neoplasm Staging; Ovarian Neoplasms	1986
[Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:9 Topics: Adult; Aged; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms	1986
[Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1 Topics: Acute Disease; Adolescent; Adult; Aged; Alopecia; Anorexia; Drug Evaluation; Etoposide; Fatigue; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin	1986
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1 Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine	1986
[Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)]. Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:8 Topics: Administration, Oral; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Male; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urogenital Neoplasms	1985
Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer. American journal of clinical oncology, 1985, Volume: 8, Issue:5 Topics: Alopecia; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Leukopenia; Lymphatic Metastasis; Podophyllotoxin	1985